Services Agreements in the Pharmaceuticals Industry

392 Contracts & Agreements

Browse by Company

Acacia Diversified Holdings, Inc. (1 contract)
Acasti Pharma Inc. (1)
Accelerated Pharma, Inc. (2)
ACELRX PHARMACEUTICALS INC (3)
Aclaris Therapeutics, Inc. (2)
ADIAL PHARMACEUTICALS, INC. (5)
AEOLUS PHARMACEUTICALS, INC. (1)
AEON Biopharma, Inc. (1)
AGILE THERAPEUTICS INC (10)
ALDER BIOPHARMACEUTICALS INC (2)
ALIMERA SCIENCES INC (3)
Amag Pharmaceuticals (9)
Amphastar Pharma (1)
Ampio Pharmaceuticals, Inc. (2)
AMYLIN PHARMACEUTICALS INC (2)
Amylyx Pharmaceuticals, Inc. (3)
Anebulo Pharmaceuticals, Inc. (2)
Applied BioSciences Corp. (2)
Arog Pharmaceuticals, Inc. (2)
Artemis Therapeutics, Inc. (1)
Assertio Therapeutics, Inc (2)
AUXILIUM PHARMACEUTICALS INC (1)
AVADEL PHARMACEUTICALS PLC (1)
AYTU BIOSCIENCE, INC (3)
Big Rock Partners Acquisition Corp. (2)
BIODELIVERY SCIENCES INTERNATIONAL INC (1)
Biofrontera Inc. (3)
Biostar Pharmaceuticals, Inc. (1)
Blue Water Acquisition Corp. (2)
Canbiola, Inc. (5)
Cancer Prevention Pharmaceuticals, Inc. (1)
Cannabics Pharmaceuticals Inc. (1)
CANNAPOWDER, INC. (1)
Canopy Growth Corp (3)
Cara Therapeutics, Inc. (2)
CARDAX, INC. (1)
CASSAVA SCIENCES INC (2)
CELGENE CORP (1)
CHINA PEDIATRIC PHARMACEUTICALS, INC. (8)
China Pharmaceuticals Inc (1)
Cingulate Inc. (2)
Citius Pharmaceuticals, Inc. (4)
COGNITION THERAPEUTICS INC (1)
CoLucid Pharmaceuticals, Inc. (1)
Context Therapeutics Inc. (1)
Corcept Therapeutics Incorporated (10)
CorMedix Inc. (1)
COSMO VENTURES INC (1)
Cronos Group Inc. (3)
CUBIST PHARMACEUTICALS INC (6)
CUMBERLAND PHARMACEUTICALS INC (1)
CymaBay Therapeutics, Inc. (1)
Dova Pharmaceuticals Inc. (4)
DUSA PHARMACEUTICALS INC (1)
Egalet Corp (1)
Elanco Animal Health Inc (3)
Eleison Pharmaceuticals Inc (3)
ELITE PHARMACEUTICALS INC (1)
Elixir Pharmaceuticals, Inc. (2)
Eloxx Pharmaceuticals, Inc. (1)
Endexx Corp (1)
Evoke Pharma Inc (10)
Evolus, Inc. (1)
EYEGATE PHARMACEUTICALS INC (2)
GREEN HYGIENICS HOLDINGS INC. (1)
GridIron BioNutrients, Inc. (1)
Haymaker Acquisition Corp. III (2)
Horizon Pharma plc (6)
Hoth Therapeutics, Inc. (1)
IDENIX PHARMACEUTICALS INC (2)
INNOVATE BIOPHARMACEUTICALS, INC. (1)
INSPIRE PHARMACEUTICALS INC (2)
Intersect ENT, Inc. (2)
Intra-Cellular Therapies, Inc. (2)
Jaguar Health, Inc. (3)
Jazz Pharmaceuticals plc (16)
Journey Medical Corp (2)
Kala Pharmaceuticals, Inc. (2)
KING PHARMACEUTICALS INC (1)
Lexaria Bioscience Corp. (6)
Lilly (Eli) & Co. (1)
Lipocine Inc. (2)
Longboard Pharmaceuticals, Inc. (1)
Luckwel Pharmaceuticals Inc. (1)
MAP Pharmaceuticals, Inc. (2)
Medicine Man Technologies, Inc. (1)
MEMORY PHARMACEUTICALS CORP (1)
Menlo Therapeutics Inc. (1)
MJ Holdings, Inc. (4)
Molecular Insight Pharmaceuticals, Inc. (1)
Mylan N.V. (1)
MYnd Analytics, Inc. (2)
Nabriva Therapeutics plc (2)
NEW RIVER PHARMACEUTICALS INC (2)
NewBridge Global Ventures, Inc. (3)
Notis Global, Inc. (1)
NovaBay Pharmaceuticals, Inc. (2)
NURX PHARMACEUTICALS, INC. (1)
OMEROS CORP (5)
One World Pharma, Inc. (1)
OPIANT PHARMACEUTICALS, INC. (3)
OPTIMER PHARMACEUTICALS INC (1)
OptiNose, Inc. (3)
ORAMED PHARMACEUTICALS INC. (6)
Pacira Pharmaceuticals, Inc. (9)
Panacea Acquisition Corp (2)
Paratek Pharmaceuticals, Inc. (14)
PaxMedica, Inc. (2)
PEAK PHARMACEUTICALS, INC. (2)
Pharmagreen Biotech Inc. (1)
Pivot Pharmaceuticals Inc. (1)
PLx Pharma Inc. (6)
Prestige Brands Holdings Inc (1)
Pulmatrix, Inc. (3)
Rani Therapeutics Holdings, Inc. (5)
Raphael Pharmaceutical Inc. (5)
Recro Pharma, Inc. (3)
RespireRx Pharmaceuticals Inc. (1)
resTORbio, Inc. (2)
Revance Therapeutics, Inc. (4)
SANCILIO PHARMACEUTICALS COMPANY, INC. (1)
SCICLONE PHARMACEUTICALS INC (5)
SCYNEXIS INC (6)
Semnur Pharmaceuticals, Inc. (2)
SenesTech, Inc. (1)
Sonoma Pharmaceuticals, Inc. (2)
SYNERGY PHARMACEUTICALS, INC. (1)
Targeted Medical Pharma, Inc. (3)
TAURIGA SCIENCES, INC. (3)
TETRALOGIC PHARMACEUTICALS CORP (1)
TherapeuticsMD, Inc. (15)
Tilray, Inc. (4)
Urovant Sciences Ltd. (5)
Valera Pharmaceuticals Inc (1)
Ventyx Biosciences, Inc. (3)
Verrica Pharmaceuticals Inc. (4)
VIA Pharmaceuticals, Inc. (1)
Virpax Pharmaceuticals, Inc. (1)
VIVUS INC (1)
Vyrix Pharmaceuticals, Inc. (1)
XANODYNE PHARMACEUTICALS INC (4)
Zoetis (2)
ZOGENIX, INC. (7)

Recent Contracts

Advisory Services Agreement, dated as of August 25, 2024, by and between 450W42ND MIMA, LLC and Semnur Pharmaceuticals, Inc (Semnur Pharmaceuticals, Inc., Filed With SEC on November 6, 2024)
Advisory Services Agreement, dated as of August 26, 2024, by and between Wise Orient Investments Limited and Semnur Pharmaceuticals, Inc (Semnur Pharmaceuticals, Inc., Filed With SEC on November 6, 2024)
Professional Services Agreement, dated November 4, 2024, by and between the Company and John J. Kirby (Verrica Pharmaceuticals Inc., Filed With SEC on November 4, 2024)
Master Services Agreement dated September 23, 2024, between Oramed Ltd. and InClin, Inc (ORAMED PHARMACEUTICALS INC., Filed With SEC on September 26, 2024)
Amended and Restated Shared Services Agreement, dated August 12, 2024, between Citius Pharmaceuticals, Inc. and Citius Oncology, Inc (Citius Pharmaceuticals, Inc., Filed With SEC on August 16, 2024)
Master Services Agreement, dated as of May 28, 2024, by and between Pulmatrix, Inc. and MannKind Corporation (Pulmatrix, Inc., Filed With SEC on August 13, 2024)
Manufacturing Services Agreement, dated as of July 17, 2024, by and between Alimera Sciences, Inc. and Alliance Medical Products, Inc. d.b.a. Siegfried Irvine (ALIMERA SCIENCES INC, Filed With SEC on August 7, 2024)
English Translation of the Amendment to the Service Agreement by and between the Company and Yehuda Eliya, dated December 25, 2023 (Raphael Pharmaceutical Inc., Filed With SEC on March 28, 2024)
Amendment No. 1 to RMS Service Agreement, dated March 15, 2024, by and between Rani Therapeutics, LLC and InCube Labs, LLC (Rani Therapeutics Holdings, Inc., Filed With SEC on March 20, 2024)
Amendment No. 2 to Service Agreement, dated March 15, 2024, by and between Rani Therapeutics, LLC and InCube Labs, LLC (Rani Therapeutics Holdings, Inc., Filed With SEC on March 20, 2024)
Manufacturing Services Agreement dated November 7, 2017, between the Company and Patheon UK Limited (Evoke Pharma Inc, Filed With SEC on March 14, 2024)
Commercial Outsourcing Services Agreement entered into as of February 26, 2024 by the Registrant and Integrated Commercialization Solutions, Inc (Pacira Pharmaceuticals, Inc., Filed With SEC on February 29, 2024)
Amendment No. 2 to the Technology Transfer, Validation and Commercial Fill/Finish Services Agreement dated February 26, 2024, by and between Revance Therapeutics, Inc. and... (Revance Therapeutics, Inc., Filed With SEC on February 28, 2024)
Commercial Manufacturing Services Agreement, dated November 13, 2023, by and between Aytu BioPharma, Inc. and Halo Pharmaceutical, Inc (AYTU BIOSCIENCE, INC, Filed With SEC on February 14, 2024)
Statement of Work #2, dated January 17, 2024, to Master Services Agreement between Adial Pharmaceuticals, Inc. and The Keswick Group, LLC, dated March 15, 2023 (ADIAL PHARMACEUTICALS, INC., Filed With SEC on January 18, 2024)
Master Service Agreement, dated August 15, 2023, between TherapeuticsMD, Inc. and JZ Advisory Group (TherapeuticsMD, Inc., Filed With SEC on November 14, 2023)
Form of Amended and Restated Shared Services Agreement (Citius Pharmaceuticals, Inc., Filed With SEC on October 24, 2023)
Seventh Amendment to Project Agreement, dated September 28, 2023, by and between Agile Therapeutics, Inc., and Syneos Health Commercial Services, LLC (AGILE THERAPEUTICS INC, Filed With SEC on September 28, 2023)
Master Intercompany Services Agreement between RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd dated August 3, 2023 (RespireRx Pharmaceuticals Inc., Filed With SEC on August 9, 2023)
Manufacturing Service Agreement by and between Amphastar Pharmaceuticals, Inc., and Eli Lilly and Company, dated June 30, 2023 (Amphastar Pharma, Filed With SEC on August 9, 2023)
Second Amendment, dated as of March 20, 2023, to Product Agreement, dated as of November 12, 2019, as amended by Amendment No. 1, dated as of January 18, 2021, pursuant to the... (Amylyx Pharmaceuticals, Inc., Filed With SEC on May 11, 2023)
First Amendment, dated as of January 18, 2021, to Product Agreement, dated as of November 12, 2019, pursuant to the Master Manufacturing Services Agreement, dated as of November... (Amylyx Pharmaceuticals, Inc., Filed With SEC on May 11, 2023)
Sixth Amendment to Project Agreement, dated January 3, 2023, by and between Agile Therapeutics, Inc. and inVentiv Commercial Services, LLC (AGILE THERAPEUTICS INC, Filed With SEC on March 23, 2023)
Master Services Agreement between Adial Pharmaceuticals, Inc. and The Keswick Group, LLC, dated March 15, 2023 (ADIAL PHARMACEUTICALS, INC., Filed With SEC on March 21, 2023)
Master Services Agreement, dated March 2, 2023, between the Company and Potrero Hill Advisors, LLC (Anebulo Pharmaceuticals, Inc., Filed With SEC on March 8, 2023)
Amendment No. 1 to Master Services Agreement dated as of December 19, 2022 by and between ITI Limited and Lonza Ltd (Intra-Cellular Therapies, Inc., Filed With SEC on March 1, 2023)
Pharmacy Master Services Agreement, dated as of (Jazz Pharmaceuticals plc, Filed With SEC on March 1, 2023)
Letter Agreement by and between Anna Shlimak and Cronos USA Client Services LLC, dated February (Cronos Group Inc., Filed With SEC on February 28, 2023)
Service Agreement, dated as of July 5, 2022, between Dr. Igal Louria Hayon and the Company (Raphael Pharmaceutical Inc., Filed With SEC on January 26, 2023)
Amendment No. 15 to the Financing Agreement, dated July 28, 2022, by and among TherapeuticsMD, Inc. as the Borrower, vitaMedMD, LLC, BocaGreenMD, Inc. and vitaCare Prescription... (TherapeuticsMD, Inc., Filed With SEC on November 14, 2022)
Amendment No. 14 to the Financing Agreement, dated July 27, 2022, by and among TherapeuticsMD, Inc. as the Borrower, vitaMedMD, LLC, BocaGreenMD, Inc. and vitaCare Prescription... (TherapeuticsMD, Inc., Filed With SEC on November 14, 2022)
Amendment No. 13 to the Financing Agreement, dated July 24, 2022, by and among TherapeuticsMD, Inc. as the Borrower, vitaMedMD, LLC, BocaGreenMD, Inc. and vitaCare Prescription... (TherapeuticsMD, Inc., Filed With SEC on November 14, 2022)
Amendment No. 12 to the Financing Agreement, dated July 13, 2022, by and among TherapeuticsMD, Inc. as the Borrower, vitaMedMD, LLC, BocaGreenMD, Inc. and vitaCare Prescription... (TherapeuticsMD, Inc., Filed With SEC on November 14, 2022)
Amendment No. 2 to the Commercial Services Agreement, dated as of November 3, 2022, between the Company and Eversana Life Sciences Services, LLC (Evoke Pharma Inc, Filed With SEC on November 9, 2022)
Amendment No. 7, dated as of September 28, 2022, to Pharmacy Master Services Agreement, dated as of (Jazz Pharmaceuticals plc, Filed With SEC on November 9, 2022)
Letter Agreement by and among John Griese, Cronos USA Client Services LLC, and Hortican Inc., dated November 7, 2022 (Cronos Group Inc., Filed With SEC on November 7, 2022)
Master Services Agreement between Cingulate Therapeutics LLC and Societal CDMO, Inc., dated October 24, 2022 (Cingulate Inc., Filed With SEC on October 25, 2022)
Form of Intercompany Services Agreement between the registrant and Hyla US Holdco Limited, effective as of August 31, 2022 (Endexx Corp, Filed With SEC on September 7, 2022)
Manufacturing Services Agreement, dated June 10, 2022, by and between Napo Pharmaceuticals, Inc. and Patheon Pharmaceuticals Inc (Jaguar Health, Inc., Filed With SEC on August 24, 2022)
Service Agreement, dated as of July 26, 2022, by and between the Company and David Dana (Artemis Therapeutics, Inc., Filed With SEC on August 2, 2022)